[1] Zhou X, Cui Y, Han J. Methylmalonic acidemia: current status and research priorities[J]. Intractable Rare Dis Res,2018,7(2):73-78. DOI: 10.5582/irdr.2018.01026.
[2] Lerner-Ellis JP, Tirone JC, Pawelek PD,et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type[J]. Nat Genet, 2006,38(1):93-100.DOI: 10.1038/ng1683.
[3] 刘怡,刘玉鹏,张尧,等. 中国1 003例甲基丙二酸血症的复杂临床表型、基因型及防治情况分析[J]. 中华儿科杂志,2018,56(6):414-420.DOI:10.3760/cma.j.issn.0578- 1310.2018.06.003.
[4] Chen T, Gao Y, Zhang S,et al. Methylmalonic acidemia: neurodevelopment and neuroimaging[J]. Front Neurosci, 2023,17:1110942.DOI: 10.3389/fnins.2023.1110942.
[5] Bakshi NA, Al-Anzi T, Mohamed SY,et al. Spectrum of bone marrow pathology and hematological abnormalities in methylmalonic acidemia[J]. Am J Med Genet A, 2018,176(3):687-691.DOI: 10.1002/ajmg.a.38599.
[6] Andrade VM, Dal Pont HS, Leffa DD,et al. Methylmalonic acid administration induces DNA damage in rat brain and kidney[J]. Mol Cell Biochem, 2014,391(1-2):137-145.DOI: 10.1007/s11010-014-1996-4.
[7] Grangé S, Bekri S, Artaud-Macari E,et al. Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency[J]. Lancet, 2015,386(9997):1011-1012. DOI: 10.1016/S0140-6736(15)00076-8.
[8] Cocuzzo B, Kalirao S. Uncommonly missed diagnosis of methylmalonic acidemia (MMA) in adults and usefulness of testing for MMA in cases of seizures/neuropathy/weakness/ataxia[J]. Cureus, 2023,15(10):e47577. DOI: 10.7759/cureus.47577.
[9] Kölker S, Garcia-Cazorla A, Valayannopoulos V,et al.The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation[J]. J Inherit Metab Dis, 2015,38(6):1041-1057.DOI: 10.1007/s10545-015-9839-3.
[10] AlOwain M, Khalifa OA, Al Sahlawi Z,et al. Optic neuropathy in classical methylmalonic acidemia[J]. Ophthalmic Genet, 2019,40(4):313-322.DOI: 10.1080/13816810.2019.1634740.
[11] Traber G, Baumgartner MR, Schwarz U,et al. Subacute bilateral visual loss in methylmalonic acidemia[J]. J Neuroophthalmol, 2011,31(4):344-346. DOI: 10.1097/WNO.0b013e31822db480.
[12] Karamifar H, Shakibazad N, Saki F,et al. Skin manifestation of methylmalonic acidemia: case report and review of the literature[J]. G Ital Dermatol Venereol, 2015,150(6):741-744.
[13] Fowler B, Leonard JV, Baumgartner MR. Causes of and diagnostic approach to methylmalonic acidurias[J]. J Inherit Metab Dis, 2008 ,31(3):350-360.DOI: 10.1007/s10545-008-0839-4.
[14] Longo N, Sass JO, Jurecka A,et al. Biomarkers for drug development in propionic and methylmalonic acidemias[J]. J Inherit Metab Dis, 2022 ,45(2):132-143.DOI: 10.1002/jimd.12478.
[15] 韩连书,高晓岚,叶军,等. 串联质谱技术在有机酸血症筛查中的应用研究[J]. 中华儿科杂志,2005,43(5):325-330. DOI:10.3760/j.issn:0578-1310.2005.05.002.
[16] Choudhari PR, Waugh JL, Lowden A. Subdural hemorrhage and focal motor status epilepticus in cobalamin metabolism disorder[J]. Pediatr Neurol, 2023,140:47-49.DOI: 10.1016/j.pediatrneurol.2022.12.007.
[17] Deleanu C, Nicolescu A. NMR spectroscopy in diagnosis and monitoring of methylmalonic and propionic acidemias[J]. Biomolecules, 2024,14(5):528. DOI: 10.3390/biom14050528.
[18] Iles RA, Hind AJ, Chalmers RA. Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias[J]. Clin Chem, 1985,31(11):1795-1801.
[19] Zhang S, Bastille A, Gordo S,et al. Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia[J]. PLoS One, 2022,17(9):e0274774.DOI: 10.1371/journal.pone. 0274774.
[20] Head PE, Myung S, Chen Y,et al. Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin[J]. Sci Transl Med, 2022,14(646):eabn4772. DOI: 10.1126/scitranslmed. abn4772.
[21] Han L, Wu S, Han F,et al. Insights into the molecular mechanisms of methylmalonic acidemia using microarray technology[J]. Int J Clin Exp Med, 2015,8(6):8866-8879.
[22] Li Y, Peng T, Li L,et al. MicroRNA-9 regulates neural apoptosis in methylmalonic acidemia via targeting BCL2L11[J]. Int J Dev Neurosci, 2014 ,36:19-24.DOI: 10.1016/j.ijdevneu.2014.04.005.
|